Galectins: A key intersection between glycobiology and immunology

Brazilian Journal of Medical and Biological Research

Volumn 32, Issue 4, 1999, Pages 383-393

  Rabinovich, G A ^a   Riera, C M ^a   Landa, C A ^a   Sotomayor, C E ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Adhesion; Apoptosis; Embryogenesis; Galectins; Immunomodulation; Metastasis

Indexed keywords

GALECTIN; HEMAGGLUTININ;

APOPTOSIS; CHEMISTRY; IMMUNOLOGY; PHYSIOLOGY; REVIEW;

APOPTOSIS; GALECTINS; HEMAGGLUTININS;

EID: 0033109559     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1999000400002     Document Type: Article

References (81)

1. Barondes SH, Cooper DNW, Gitt MA & Leffler H (1994). Galectins: structure and function of a large family of animal lectins. Journal of Biological Chemistry, 269: 20807-20810.
2. Barondes SH, Castronovo V, Cooper DNW, Cummings RD, Drickamer K, Feizi T, Gitt MA, Hirabayashi J, Hughes C, Kasai K, Leffler H, Liu F, Lotan R, Mercuric AM, Monsigni M, Pillai S, Poirer F, Raz A, Rigby PWJ, Rini JM & Wang JL (1994). Galectins: a family of animal galactoside-binding lectins. Cell, 76: 597-598.
3. Kasi K & Hirabayashi J (1996). Galectins: a family of animal lectins that decipher glycocodes. Journal of Biochemistry, 119: 1-8.
4. Leffler H (1997). Introduction to galectins. Trends in Glycoscience and Glycotechnology, 45: 9-19.
5. Hirabayashi J & Kasai K (1993). The family of metazoan metal-independent ß-galactoside-binding lectins: structure, function and molecular evolution. Glycobiology, 3: 297-304.
6. Hirabayashi J & Kasai K (1984). Human placenta ß-galactoside-binding lectin. Purification and some properties. Biochemical and Biophysical Research Communications, 122: 938-944.
7. Gitt MA & Barondes SH (1991), Genomic sequence and organization of two members of a human lectin gene family. Biochemistry, 30: 82-89.
8. Gitt MA, Massa SM, Leffler H & Barondes SH (1992). Isolation and expression of a gene encoding L-14-II, a new human soluble lactose-binding lectin. Journal of Biological Chemistry, 267: 10601-10606.
9. Gitt MA, Wisers MF, Leffler H, Herrmann J, Xia Y-R, Massa SM, Cooper DNW, Luis AJ & Barondes SH (1995). Sequence and mapping of galectin-5, a ß-galactoside-binding lectin, found in rat erythrocytes. Journal of Biological Chemistry, 270: 5032-5038.
10. Magnaldo T, Bernerd F & Darmon M (1995). Galectin-7, a human 14-kDa S-lectin, specifically expressed in keratinocytes and sensitive to retinoic acid. Developmental Biology, 168: 259-271.
11. Ackerman SJ, Corrette SE, Rosenberg HF, Bennet JC, Mastrianni DM, Nicholson-Weller A, Weller PF, Chin DT & Tenen DG (1993). Molecular cloning and characterization of human eosinophil Charcot-Leyden cristal protein (lysophospholipase). Journal of Immunology, 150: 456-468
12. Vasta GR, Ahmed H, Amzel LM & Bianchet MA (1997). Galectins from amphibian species: carbohydrate specificity, molecular structure and evolution. Trends in Glycoscience and Glycotechnology, 9: 131-144.
13. Paroutaud P, Levi G, Teichberg VI & Strosberg AD (1987). Extensive amino acid homologies between animal lectins. Proceedings of the National Academy of Sciences, USA, 84: 6345-6348.
14. Hirabayashi J, Ubukata T & Kasai K (1996). Purification and molecular characterization of a novel 16-kDa galectin from the nematode Caenorhabditis elegans. Journal of Biological Chemistry, 271: 2497-2505.
15. Ohyama Y, Hirabayashi J, Oda Y, Oono S, Kawasaki H, Suzuki K & Kasai K (1986). Nucleotide sequence of chick 14 K ß-galactoside-binding lectin mRNA. Biochemical and Biophysical Research Communications, 134: 51-56.
16. Sakakura Y, Hirabayashi J, Oda Y, Ohyama Y & Kasai K (1990). Structure of chicken 16-kDa ß-galactoside-binding lectin: complete amino acid sequence, cloning of cDNA and production. Journal of Biological Chemistry, 265: 21573-21579.
17. Pfeifer K, Haasemann M, Gamulin V, Bretting H, Fahrenholz F & Muller WE (1993). S-type lectins occur also in invertebrates: high conservation of the carbohydrate recognition domain in the lectin genes from the marine sponge Geodia cydonium. Glycobiology, 3: 179-184.
18. Sato S & Hughes RC (1994). Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages. Journal of Biological Chemistry, 269: 4424-4430.
19. Nurminskaya M & Linsenmayer TF (1996). Identification and characterization of up-regulated genes during chondrocyte hypertrophy. Developmental Dynamics, 206: 260-271.
20. Oda Y, Herrmann J, Gitt MA, Turck CW, Burlingame AL, Barondes SH & Leffler H (1993). Soluble lactose-binding lectin from rat intestine with two different carbohydrate-binding domains in the same chain. Journal of Biological Chemistry, 268: 5929-5939.
21. Gitt MA, Colnot C, Poirier F, Nani KJ, Barondes SH & Leffler H (1998). Galectin-4 and galectin-6 are two closely related lectins expressed in mouse gastrointestinal tract. Journal of Biological Chemistry, 273: 2954-2960.
22. Hadari YR, Paz K, Dekel R, Mestrovic T, Accili D & Zick Y (1995). Galectin-8: a new rat lectin related to galectin-4. Journal of Biological Chemistry, 270: 3447-3453.
23. Wada J & Kanwar YS (1997). Identification and characterization of galectin-9, a novel ß-galactoside-binding mammalian lectin. Journal of Biological Chemistry, 272: 6078-6086.
24. Rabinovich GA, Castagna LF, Landa CA, Riera CM & Sotomayor CE (1996). Regulated expression of a 16-kd galectin-like protein in activated rat macrophages. Journal of Leukocyte Biology, 59: 363-370.
25. Dagher SF, Wang JL & Patterson RJ (1995). Identification of galectin-3 as a factor in pre-mRNA splicing. Proceedings of the National Academy of Sciences, USA, 92: 1213-1217.
26. Cooper DNW (1997). Galectin-1: secretion and modulation of cell interactions with laminin. Trends in Glycoscience and Glycotechnology, 9: 57-67.
27. Cooper DNW & Barondes SH (1990). Evidence for export of a muscle lectin from cytosol to extracellular matrix and for novel secretory mechanism. Journal of Cell Biology, 110: 1681-1691.
28. Poirier F, Timmons PM, Chan C-T, Guenet J-L & Rigby P (1992). Expression of the L14 lectin during mouse embryogenesis suggests multiple roles during pre-and post-implantation development. Development, 115: 143-155.
29. Gillenwater A, Xu XC, Estrov Y, Sacks PG, Lotan D & Lotan R (1998). Modulation of galectin-1 content in human head and neck squamous carcinoma cells by sodium butyrate. International Journal of Cancer, 75: 217-224.
30. Hsu DK, Hammes SR, Kuwabara I, Greene WC & Liu FT (1996) Human T lymphotropic virus-I infection of human T lymphocytes induces expression of the beta-galactoside binding lectin, galectin-3. Journal of Biological Chemistry, 148: 1661-1670.
31. Gaudin JC, Arar C, Monsigny M & Legrand A (1997). Modulation of the expression of the rabbit galectin-3 gene by p53 and c-Ha-ras proteins and PMA. Glycobiology 7: 1089-1098.
32. Rabinovich GA, Iglesias MM, Modesti NM, Castagna LF, Wolfenstein-Todel C, Riera CM & Sotomayor CE (1998). Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T cells: biochemical and functional characterization. Journal of Immunology, 160: 4831-4840.
33. Cleves AE, Cooper DN, Barondes SH & Kelly RB (1996). A new pathway for protein export in Saccharomyces cerevisiae. Journal of Cell Biology, 133: 1017-1026.
34. Rubartelli A, Bajetto A, Allavena G, Wollman E & Sitia R (1992). Secretion of thioredoxin by normal and neoplastic cells through leaderless secretory pathway. Journal of Biological Chemistry, 267: 24161-24164.
35. Poirrier F & Robertson EJ (1993). Normal development of mice carrying a null mutation in the gene encoding the L-14 S-type lectin. Development 119: 1229-1236.
36. Colnot C, Fowlis D, Ripoche MA, Bouchaert I & Poirier F (1998). Embryonic implantation in galectin-1/galectin-3 double mutant mice. Developmental Dynamics, 211: 306-313.
37. Colnot C, Ripoche MA, Fowlis D, Cannon V, Scaerou F, Cooper DNW & Poirier F (1997). The role of galectins in mouse development. Trends in Glycoscience and Glycotechnology, 9: 31-40.
38. Wells V & Mallucci L (1991). Identification of an autocrine negative growth factor: mouse ß-galactoside-binding protein is a cytostatic factor and cell growth regulator. Cell, 64: 91-97.
39. Offner H, Celnik B, Bringman T, Casentini-Borocz D, Nedwin GE & Vandebark A (1990). Recombinant human ß-galactoside-binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology, 28: 177-184.
40. Levy G, Tarrab-Hazdai R & Teichberg VI (1983). Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits. European Journal of Immunology, 13: 500-507.
41. Perillo NL, Pace KE, Seilhamer JJ & Baum LG (1995). Apoptosis of T-cells mediated by galectin-1. Nature, 378: 736-739.
42. Yamaoka A, Kuwabara I, Frigeri LG & Liu FT (1995). A human lectin, galectin-3 (epsilon BP/Mac-2), stimulates superoxide production by neutrophils. Journal of Immunology, 154: 3479-3487.
43. Iglesias MM, Rabinovich GA, Ivanovic V, Sotomayor CE & Wolfenstein-Todel C (1998). Galectin-1 from ovine placenta: amino-acid sequence, physicochemical properties and implications in T-cell death. European Journal of Biochemistry, 252: 400-407.
44. Iglesias MM, Rabinovich GA, Ambrosio AL, Castagna LF, Sotomayor CE & Wolfenstein-Todel CW (1998). Purification of galectin-3 from ovine placenta: developmentally regulated expression and immunological relevance. Glycobiology, 8: 59-65.
45. Raz A & Lotan R (1987). Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis. Cancer and Metastasis Reviews, 6: 433-452.
46. Zhou Q & Cummings RD (1993). L-14 lectin recognition of laminin and its promotion of in vitro cell adhesion. Archives of Biochemistry and Biophysics, 300: 6-17.
47. Ozeki Y, Matsui T, Yamamoto Y, Funahashi M, Hamako J & Titani K (1995). Tissue fibronectin is an endogenous ligand for galectin-1. Glycobiology, 5: 255-261.
48. Van den Brüle FA, Buicu C, Baldet M, Sobel ME, Cooper DNW, Marschal P & Castronovo V (1995). Galectin-1 modulates human melanoma cell adhesion to laminin. Biochemical and Biophysical Research Communications, 209: 760-767.
49. Mahanthappa NK, Cooper DNW, Barondes SH & Schwarting GA (1994). Rat olfactory neurons can utilize the endogenous lectin L-14, in a novel adhesion mechanism. Development, 120: 1373-1384.
50. Cooper DNW, Massa SM & Barondes SH (1991). Endogenous muscle lectin inhibits myoblast adhesion to laminin. Journal of Cell Biology, 115: 1437-1448.
51. Kuwabara I & Liu F-T (1996). Galectin-3 promotes adhesion of human neutrophils to laminin. Journal of Immunology, 156: 3939-3944.
52. Ochieng J, Leite-Browning ML & Warfield P (1998). Regulation of cellular adhesion to extracellular matrix proteins by galectin-3. Biochemical and Biophysical Research Communications, 246: 788-791.
53. Bresalier RS, Mazurek N, Sternberg LR, Byrd JC, Yunker CK, Makker PN & Raz A (1998). Metastasis of human colon cancer is altered by modifying expression of the ß-galactoside binding protein galectin-3. Gastroenterology, 115: 287-296.
54. Sanford GL & Harris-Hooker S (1990). Stimulation of vascular cell proliferation by ß-galactoside-binding lectins. FASEB Journal, 4: 2912-2918.
55. Adams L, Kenneth Scott G & Weinberg C (1996). Biphasic modulation of cell growth by recombinant human galectin-1. Biochimica et Biophysica Acta, 1312: 137-144.
56. Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF & Sporn MB (1985). Type beta transforming growth factor: a bifunctional regulator of cell growth. Proceedings of the National Academy of Sciences, USA, 82: 119-123.
57. Lynch DH, Ramsdell F & Alderson MR (1995). Fas and Fas L in the homeostatic regulation of immune responses. Immunology Today, 16: 569-574.
58. Karlsson A, Follin P, Leffler H & Dahigren C (1998). Galectin-3 activates the NADPH oxidase in exudated but not peripheral blood neutrophils. Blood, 91: 3430-3438.
59. Matsumoto R, Matsumoto H, Seki M, Hata M, Asano Y, Kanegasaki S, Stevens RL & Hirashima M (1998). Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. Journal of Biological Chemistry, 273: 16976-16984.
60. Ogden AT, Nunes I, Ko K, Wu S, Hines CS, Wang AF, Hegde RS & Lang RA (1998). GRIFIN, a novel lens-specific protein related to the galectin family. Journal of Biological Chemistry, 273: 28889-28896.
61. Griffith TS & Ferguson TA (1997). The role of Fas L-induced apoptosis in immune privilege. Immunology Today, 18: 240-244.
62. Gold R, Hartung HP & Lassman H (1997). T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanism. Trends in Neurosciences, 20: 399-404.
63. Baum LG, Seilhamer JJ, Pang M, Levine WB, Beynon D & Berliner JA (1995). Synthesis of an endogenous lectin, galectin-1 by human endothelial cells is up-regulated by endothelial cell activation. Glycoconjugate Journal, 12: 63-68.
64. Baum LG, Pang M, Perillo NL, Wu T, Delegaene A, Uittenbogaart CH, Fukuda M & Seilhamer JJ (1995). Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells. Journal of Experimental Medicine, 181: 877-887.
65. Blaser C, Kaufmann M, Muller C, Zimmerman C, Wells V, Mallucci L & Pircher H (1998). ß-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. European Journal of Immunology, 28: 2311-2319.
66. Allione A, Wells V, Forni G, Mallucci L & Novelli F (1998). ß-galactoside-binding protein (ß-GBP) alters the cell cycle, up-regulates expression of the α-and ß-chains of the IFN-γ receptor, and triggers IFN-γ-mediated apoptosis of activated human T lymphocytes. Journal of Immunology, 161: 2114-2119.
67. Cortegano I, del Pozo V, Cárdaba B, de Andres B, Gallardo S, del Amo A, Arrieta I, Jurado A, Palomino P, Liu F-T & Lahoz C (1998). Galectin-3 down-regulates IL-5 gene expression on different cell types. Journal of Immunology, 161: 385-389.
68. Goldstone SD & Lavin MF (1991). Isolation of a cDNA clone, encoding a human ß-galactoside-binding protein overexpressed during glucocorticoid-induced cell death. Biochemical and Biophysical Research Communications, 178: 746-750.
69. von Boehmer H (1994). Positive selection of lymphocytes. Cell, 76: 219-228.
70. Nossal GJV (1994). Negative selection of lymphocytes. Cell, 76: 229-239.
71. Perillo NL, Uittenbogaart CH, Nguyen JT & Baum LG (1997). Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes. Journal of Experimental Medicine, 97: 1851-1858.
72. McFarland HL, Critchfield JM, Racke MK, Mueller JP, Nye SH, Boehme SA & Lenardo MJ (1995). Amelioration of autoimmune reactions by antigen-induced apoptosis of T cells. Advances in Experimental and Medical Biology, 383: 157-166.
73. Cyster JG, Fowell D & Barclay AN (1994). Antigen determinants encoded by alternatively spliced exons of CD45 are determined by the polypeptide but influenced by glycosylation. International Immunology, 6: 1875-1881.
74. Singer GG, Carrera AC, Marshak-Rothstein A, Martinez AC & Abbas AK (1994). Apoptosis, Fas and systemic autoimmunity: the MRL-Ipr/Ipr model. Current Opinion in Immunology, 6: 913-920.
75. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middelton LA, Yin AY, Strober W, Lenardo MJ & Puck JM (1995). Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell, 81: 935-946.
76. Yang RY, Hsu DK & Liu FT (1996). Expression of galectin-3 modulates T cell growth and apoptosis. Proceedings of the National Academy of Sciences, USA, 93: 6737-6742.
77. Kroemer G (1997). The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Medicine, 3: 614-620.
78. Wada J, Ota K, Kumar A, Wallner EI & Kanwar Y (1997). Developmental regulation, expression and apoptotic potential of galectin-9, a ß-galactoside-binding lectin. Journal of Clinical Investigation, 99: 2452-2461.
79. Rabinovich GA, Modesti NM, Castagna LF, Landa CA, Riera CM & Sotomayor CE (1997). Specific inhibition of lymphocyte proliferation and induction of apoptosis by CLL-I, a ß-galactoside-binding lectin. Journal of Biochemistry, 122: 365-373.
80. Revillard JP, Adorini L, Goldman M, Kabelitz D & Waldmann H (1998). Apoptosis: potential for disease therapies. Immunology Today, 19: 291-293.
81. Lutomski D, Joubert-Caron R, Lefebure C, Salama J, Belin C, Bladier D & Caron M (1997). Anti-galectin-1 autoantibodies in serum of patients with neurological diseases. Clinica Chimica Acta, 262: 131-138.